CAS 2250440-41-4

Vilobelimab

CAS : 2250440-41-4

Vilobelimab (CaCP-29, IFX-1), a monoclonal antibody, inhibits C5a to reduce inflammation and is researched in sepsis and COVID-19 studies.

Degré de pureté : 99% (SDS-PAGE); 98.9% (SEC-HPLC) - 99% (SDS-PAGE); 98.9% (SEC-HPLC)

Couleur et forme : Liquid

Masse moléculaire : 145.86 kDa

Ref: TM-T76958